Core Scientific reported a Q1 net loss despite increased revenue, primarily due to impairment charges.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
Germany’s Infamous $2.89 Billion Bitcoin Sale Is Suddenly Looking Smarter
OpenAI Plans Biggest ChatGPT Overhaul Before IPO
HTX to delist Trump-linked USD1 after saying World Liberty Financial froze exchange-linked addresses
Bitcoin, ether eye worst weekly rout since FTX collapse as cryptos shed $390 billion
Hyperion DeFi to unwind $29 million in HYPE deals with Felix, Native Markets as USDH sunsets
Hyperliquid’s UK warning reveals the regulatory test behind its Wall Street push
MicroStrategy CEO Sells $11 Million Worth of Shares
This Hidden AI Stock Up 5,100% While Bitcoin and Ethereum Lost Nearly 40%
Wallet linked to Ethereum co-founder Joseph Lubin moves 110,000 ETH to defend $259M DAI debt position
AI’s $800 billion spending boom is becoming Bitcoin’s Fed problem
